PF-04603629

BIOLOGICAL2 trials

Sponsors

Pfizer

Conditions

Diabetes Mellitus, Type 2

Phase 1

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

TerminatedNCT00637338

PfizerDiabetes Mellitus, Type 2

Start: 2008-04-30End: 2008-09-30Updated: 2009-07-31

Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects

CompletedNCT00638313

PfizerDiabetes Mellitus, Type 2

Start: 2007-08-31End: 2008-02-29Updated: 2009-07-31